sellModerate cluster of 310b5-1 plan
Troy A. Ignelzi sold $3.7M of KRTX
Chief Financial Officer at Karuna Therapeutics, Inc.. 16,500 shares at an average of $225.85, traded Nov 15, 2022, filed Nov 17, 2022.
Warning score
47Value
$3.7M
16,500 shares
Holdings after
9,970
-62% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +22RoleCFO
- +25Trade size$3.7M at market
- +20Share of holdings soldSold 62% of holdings
- +15Cluster3 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001593968-22-001609, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 15, 2022 | MOption exercise Common Stock | +16,500 | $9.20 | $152k | 26,470 | Nov 17, 2022 |
| Nov 15, 2022 | SOpen-market sale Common Stock10b5-1 | -16,500 | $225.85 | $3.7M | 9,970 | Nov 17, 2022 |
| Nov 15, 2022 | MOption exercise Option (right to buy)derivative | -16,500 | $0.00 | $0 | 121,612 | Nov 17, 2022 |
Related signals
Other insiders at Karuna Therapeutics, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 10Weak | Karuna Therapeutics, Inc. | Stephen K. Brannan Chief Medical Officer | $1.6M 5,000 shares | -11% | |
| 10Weak | Karuna Therapeutics, Inc. | Stephen K. Brannan Chief Medical Officer | $1.6M 5,000 shares | -11% | |
| 15Weak | Karuna Therapeutics, Inc. | Stephen K. Brannan Chief Medical Officer | $4.8M 15,000 shares | -28% | |
| 10Weak | Karuna Therapeutics, Inc. | Stephen K. Brannan Chief Medical Officer | $2.0M 10,000 shares | -22% | |
| 8Weak | Karuna Therapeutics, Inc. | Stephen K. Brannan Chief Medical Officer | $889k 5,000 shares | -13% | |
| 23Weak | Karuna Therapeutics, Inc. | Stephen K. Brannan Chief Medical Officer | $1.0M 5,000 shares | -27% | |
| 38Weak | Karuna Therapeutics, Inc. | Andrew Craig Miller Chief Operating Officer | $3.4M 15,000 shares | -57% | |
| 35Weak | Karuna Therapeutics, Inc. | Andrew Craig Miller Chief Operating Officer | $3.4M 15,000 shares | -37% | |
| 30Weak | Karuna Therapeutics, Inc. | Stephen K. Brannan Chief Medical Officer | $1.1M 5,000 shares | -25% | |
| 35Weak | Karuna Therapeutics, Inc. | Andrew Craig Miller Chief Operating Officer | $3.4M 15,000 shares | -28% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.